Skip to main content

Table 1 Median number and interquartile range (IQR) of different ADE categories identified for studies using different assessment methods

From: A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients

 

Number of studies*

median number of ADE categories (IQR)

References

Method of ADE assessment

   

Medical record review

18

2 (1-3)

[22, 25, 34, 35, 38, 40, 41, 49–52, 78–83]

Surveillance by HCP

17

4 (2-7)

[23, 29, 30, 42, 43, 84–95]

Patient survey

15

1 (1-2)

[18–24, 26, 31, 40, 44, 46, 53, 56]

Administrative data

5

1 (1-1)

[33, 47, 54, 96, 97]

Laboratory/clinical values

25

1 (1-2)

[25–28, 32, 35–37, 39–41, 44, 45, 50, 55, 57, 80–83, 98–101]

Non-specified

7

2 (1-10)

[27, 28, 36, 48, 99–101]

  1. * Total exceeds 68 since one study may use several methods